Cure My Disease

Don't miss your cure!

 Log in / Sign up

Health coaching may empower dialysis patients to take control of their own care

NCT ID NCT07685626

Disease control Sponsor: Anhui Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether a structured health coaching program can help people on maintenance hemodialysis better manage their own health. Participants receive one-on-one coaching during dialysis sessions plus follow-up support through a messaging app. The goal is to improve self-management skills, disease knowledge, and treatment adherence. The study involves 60 adults with end-stage kidney disease who have been on dialysis for at least three months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
health coaching
What this could lead to
If it works, this could point toward a simple, low-cost way to help dialysis patients take better care of themselves and improve their quality of life.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The coaching program requires active participation, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients aged ≥18 years who met the diagnostic criteria for ESRD according to the KDIGO 2012 Clinical Practice Guideline, namely a glomerular filtration rate of less than 15 mL/min/1.73 m². 2. Patients who have received regular maintenance hemodialysis for at least 3 months, with a dialysis frequency of three times per week. 3. Patients with a relatively stable clinical condition and no severe complications that may affect participation in the study. 4. Patients who are conscious, have normal communication ability, and are able to cooperate in completing the study procedures and questionnaires. 5. Patients who have no plan to change dialysis centers or travel for an extended period during the intervention period. 6. Patients who voluntarily agree to participate in this study and provide informed consent. Exclusion Criteria: 1. Patients with severe cognitive impairment, mental disorder, or communication difficulties that prevent participation in the intervention or completion of questionnaires. 2. Patients with severe acute illness or unstable clinical condition. 3. Patients who are unable or unwilling to complete the 6-month intervention or follow-up. 4. Patients participating in another similar intervention study during the same period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End stage kidney disease (ESKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End stage kidney disease (ESKD) Maintenance hemodialysis (MHD)

Contacts and locations

Locations

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, 230601, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.